FEATURED
-
Clinical Year in Review Series Begins with Insights on Asthma, Interventional Pulmonary, Pulmonary Function Tests, and Sleep
on
Read more: Clinical Year in Review Series Begins with Insights on Asthma, Interventional Pulmonary, Pulmonary Function Tests, and SleepThe first session of the Clinical Year in Review series began with an exploration of evolving concepts and practice-changing studies in asthma, interventional pulmonary medicine, pulmonary function tests, and sleep medicine on Sunday, May 18, at the ATS 2025 International Conference.
-
Second Clinical Year in Review Session Explores Practice-Changing Findings and Emerging Concepts in General Critical Care, Sepsis, and More
on
-
Third Clinical Year in Review Session Traces the Leading Edge in Bronchiectasis, Interstitial Lung Disease, Lung Transplant, and Pulmonary Infections
on
-
Final Clinical Year in Review Session Highlights Advances in COPD, Pulmonary Vascular Disease, Pulmonary Rehabilitation, and Lung Cancer
on
MORE #ATS2025 NEWS
-
Experts Encourage ATS Attendees to Take Action for Air Quality at Tuesday’s Keynote
on
Read More: Experts Encourage ATS Attendees to Take Action for Air Quality at Tuesday’s KeynoteA panel of experts challenged ATS members and ATS 2025 International Conference attendees to help patients and regional leaders understand and act on the increasing importance of air quality for individuals and community health during the Keynote Series session, “Improving Air Quality and Health: Current Challenges and Opportunities.”
-
Plenary Speaker Recounts Resilient Journey After Alpha-1 Antitrypsin Deficiency Diagnosis
on
Read More: Plenary Speaker Recounts Resilient Journey After Alpha-1 Antitrypsin Deficiency DiagnosisLen Geiger was the featured speaker at the ATS 2025 International Conference Plenary Session. Diagnosed with Alpha-1 antitrypsin deficiency in 1994, Mr. Geiger has turned his personal health journey into a mission to educate, inspire, and drive meaningful change for others.
-
President’s Symposium Explores Many Facets of Underdiagnosed Alpha-1 Antitrypsin Deficiency
on
Read More: President’s Symposium Explores Many Facets of Underdiagnosed Alpha-1 Antitrypsin DeficiencyThe “ATS President’s Symposium: Alpha-1 Breakthroughs: New Discoveries in Mechanisms, Diagnosis & Treatment of Lung Disease in Alpha-1 Antitrypsin Deficiency” examined critical gaps in knowledge about the disease at ATS 2025 San Francisco.
-
Pitch for Incentive Spirometry Device Wins 2025 BEAR Cage Competition
on
Read More: Pitch for Incentive Spirometry Device Wins 2025 BEAR Cage CompetitionYi-an Hsieh, MSE, and Joshua Freedman, MSE, co-founders of Airalux Medical, won the ATS 2025 BEAR Cage competition and a $10,000 prize at ATS 2025 San Francisco for their pitch, “Digital Incentive Spirometer to Improve Patient Adherence and Clinical Workflows.”
-
Early Career Programs Connect and Enrich Next Generation of Respiratory Medicine Professionals
on
Read More: Early Career Programs Connect and Enrich Next Generation of Respiratory Medicine ProfessionalsMore than 500 students and young professionals pursuing a career in pulmonary, critical care, and sleep medicine converged in San Francisco to attend the Early Career Programs at the ATS 2025 International Conference, where they learned about the latest technologies, scientific discoveries, and guidelines in the field.
-
ATS 2026 International Conference Call for Input Open Now
on
Read More: ATS 2026 International Conference Call for Input Open NowThe ATS 2026 International Conference will take place May 15-20, 2026, in Orlando, but the call for input for next year’s conference has already opened! Submit your proposals for numerous International Conference programs in all areas of respiratory, critical care, and sleep medicine, with a clinical, basic science, and/or translational focus.